<?xml version="1.0" encoding="UTF-8"?>
<ref id="B16-vaccines-07-00091">
 <label>16.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>De Filette</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Ramne</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Birkett</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Lycke</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Lowenadler</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Min Jou</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Saelens</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Fiers</surname>
    <given-names>W.</given-names>
   </name>
  </person-group>
  <article-title>The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection</article-title>
  <source>Vaccine</source>
  <year>2006</year>
  <volume>24</volume>
  <fpage>544</fpage>
  <lpage>551</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2005.08.061</pub-id>
  <pub-id pub-id-type="pmid">16169634</pub-id>
 </element-citation>
</ref>
